Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,196.00
+66.00 (3.10%)
Jun 29, 2026, 1:16 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.23 billion as of June 29, 2026. Its market cap has decreased by -13.32% in one year.
Market Cap
1.23B
Enterprise Value
1.03B
Revenue
573.62M
Ranking
n/a
PE Ratio
19.31
Stock Price
2,196.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.23B, an increase of 1,356.67%. That is a compound annual growth rate of 13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.23B | -5.74% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 116.00B |
| InterCure | 173.18M |
| Rekah Pharmaceutical Industry | 121.68M |
| Seach Medical Group | 79.83M |
| Together Pharma | 40.99M |
| Nextage Therapeutics | 14.73M |
| Tikun Olam-Cannbit Pharmaceuticals | 9.92M |
| PsyRX CNS Bio-Tech | 9.13M |